Efectividad y seguridad en el mundo real de la terapia con bomba de insulina aumentada por sensor en adultos con diabetes tipo 1: Seguimiento a largo plazo

Nicolás Coronel-Restrepo, Víctor Manuel Blanco, Andres Palacio, Alex Ramírez-Rincón, Sebastián Arbeláez, Valentina Duque, Juan José Pino, Javier Carvajal, Jorge Bedoya, Diana Paola Cuesta, José Fernando Botero

    Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

    Resumen

    Objective: To evaluate the effectiveness and safety of sensor-augmented insulin pump therapy (SAP) in addition to a comprehensive diabetes program on glycated hemoglobin (HbA1c), severe hypoglycemia, ketoacidosis, and the hospital admission rate in patients with type 1 diabetes under real-world settings during a 2-year follow-up. Methods: This was a retrospective real-life study comparing diabetes control before and after SAP therapy initiation. Patients ≥18 years old with type 1 diabetes were included. They were followed for 2 years with clinical assessments at months 3, 6, 12, 18, and 24. Effectiveness was estimated by difference in medians of HbA1c from baseline and at each follow-up visit. Safety was assessed by comparing the annual rates of severe hypoglycemia, hyperglycemic crisis, and hospital admission related to diabetes. Results: 162 patients were included, median age 32 years, women 73%). The main indication for SAP was poor metabolic control (51.2%). At 2 years HbA1c decreased from 8.4% to 7.5% (−0.9%, 95% CI: 0.5–1.2; p < 0.0001), HbA1c ≤7% improved from 14.2% to 25.3% (11.1%, 95% CI: 19.7–2.5; p = 0.006), and severe hypoglycemia decreased from 22.2% to 14.1% (−8.1%, 95% CI: −16.5 to 0.3; p = 0.03). Conclusions: SAP therapy improved glycemic control after the third month of use and for up to 2 years of follow-up, with lower rates of hospital admission and severe hypoglycemia. More studies are needed to assess the add-on impact of education programs and technologies for diabetes care.

    Título traducido de la contribuciónReal-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up
    Idioma originalEspañol
    Páginas (desde-hasta)567-572
    Número de páginas6
    PublicaciónEndocrinologia, Diabetes y Nutricion
    Volumen68
    N.º8
    DOI
    EstadoPublicada - oct. 2021

    Nota bibliográfica

    Publisher Copyright:
    © 2020 SEEN y SED

    Palabras clave

    • Continuous glucose monitoring
    • Continuous insulin infusion systems
    • Glycated hemoglobin A1c
    • Sensor-augmented insulin pump therapy
    • Type 1 diabetes mellitus
    • Type 2 diabetes mellitus

    Huella

    Profundice en los temas de investigación de 'Efectividad y seguridad en el mundo real de la terapia con bomba de insulina aumentada por sensor en adultos con diabetes tipo 1: Seguimiento a largo plazo'. En conjunto forman una huella única.

    Citar esto